What AI says about Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company focused on the research, development, and commercialization of biosimilars. The company leverages its R&D expertise to build a pipeline of products and partners with other organizations to bring these therapies to market.
AI named Samsung Bioepis in January 2026.